TY - JOUR T1 - Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC JO - Journal of Thoracic Oncology UR - http://eprints.whiterose.ac.uk/101657/ PY - 2016/09/01 AU - Arriola E AU - Wheater M AU - Galea I AU - Cross N AU - Maishman T AU - Hamid D AU - Stanton L AU - Cave J AU - Geldart T AU - Mulatero C AU - Potter V et al ED - DO - DOI: 10.1016/j.jtho.2016.05.028 PB - Elsevier VL - 11 IS - 9 SP - 1511 EP - 1521 Y2 - 2025/05/02 ER -